Found 17 matching trials
A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors
PHASE1This is a single-center, single-arm ,open-label ,dose escalation and dose e...
Location
Multiple Locations
A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies
PHASE1This is an open label, multicenter, phase 1/2 dose evaluation and cohort ex...
Anti-CD70-CAR-T Cell Injection for the Treatment of Locally Advanced or Relapsed/Metastatic CD70+ Inoperable Renal Cells
EARLY_PHASE1This is an investigator-initiated trial to evaluate the role of anti-CD70-C...
Location
Changzheng hospital
A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors
PHASE1This is an open-label, multicenter, Phase 1/2 study evaluating the safety a...
Anti-CD70 CAR-T Cell Injection in Patients With CD70-positive Advanced Urologic Neoplasms
PHASE1This is a single-arm, open-label, exploratory clinical study to evaluate th...
Location
Changhai Hospital
Universal Anti-CD70 CAR-T (CHT101) Cell Therapy for Relapsed Refractory Systemic Lupus Erythematosus
EARLY_PHASE1This investigator-initiated trial aims to evaluate the safety and efficacy ...
Location
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
CD70-CAR-NK Cell Therapy for T Cell Lymphoma and Acute Myeloid Leukemia
PHASE1CD70 is a promising target for immunotherapy because it is overexpressed in...
Location
The Second Affiliated Hospital, Zhejiang University School of Medicine
CHT105 for the Treatment of Refractory Lupus Nephritis
NASystemic lupus erythematosus (SLE) is the most common systemic autoimmune d...
Status
Enrolling By Invitation
Location
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Study of Therapeutic Efficacy of CAR-T Cell Therapy in Patients With MDR-SRNS
PHASE1This is an investigator-initiated trial aimed at assessing the safety and e...
Location
Children's Hospital, Zhejiang University School of Medicine
UCL70805F in Patients With CD70-positive Advanced Renal Clear Cell Carcinoma
PHASE1This is a single-arm, open-label, exploratory clinical study to evaluate th...
Location
The First Affiliated Hospital of Zhengzhou University